Search research articles
Contact Us
Filters
Showing results (91-100 of 138) with videos related to
Page
of 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2017
A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)
L Zhang, S Lu, J Feng, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 14, 2020
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives
M Aapro, P Bossi, A Dasari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2016
Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)
M Aapro, H Ludwig, C Bokemeyer, et al.
Schweizerische Medizinische Wochenschrift
|
March 12, 1988
[Super intensive treatment followed by bone marrow autograft in cases of hematologic neoplasms and solid tumors]
B Chapuis, C Helg, P Maurice, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 25, 2014
A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia
Heinz Ludwig, M Aapro, C Bokemeyer, et al.
Cancer Treatment Reviews
|
September 1, 1990
Batanopride (BMY-25801): a new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis
L Smaldone, P Plezia, D Alberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 1997
Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden
F Nolè, F de Braud, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2003
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron
R Gralla, M Lichinitser, S Van Der Vegt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Phase II study of tauromustine in malignant glioma
A Gregor, R Rampling, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 2009
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population
A G Pallis, C Gridelli, J P van Meerbeeck, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 138) with videos related to
Sort By:
Page
of 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2017
A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)
L Zhang, S Lu, J Feng, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 14, 2020
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives
M Aapro, P Bossi, A Dasari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2016
Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)
M Aapro, H Ludwig, C Bokemeyer, et al.
Schweizerische Medizinische Wochenschrift
|
March 12, 1988
[Super intensive treatment followed by bone marrow autograft in cases of hematologic neoplasms and solid tumors]
B Chapuis, C Helg, P Maurice, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 25, 2014
A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia
Heinz Ludwig, M Aapro, C Bokemeyer, et al.
Cancer Treatment Reviews
|
September 1, 1990
Batanopride (BMY-25801): a new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis
L Smaldone, P Plezia, D Alberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 1997
Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden
F Nolè, F de Braud, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2003
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron
R Gralla, M Lichinitser, S Van Der Vegt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Phase II study of tauromustine in malignant glioma
A Gregor, R Rampling, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 2009
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population
A G Pallis, C Gridelli, J P van Meerbeeck, et al.
Page
of 14